Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors - Archive ouverte HAL
Article Dans Une Revue Clinical Colorectal Cancer Année : 2010

Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors

Domaines

Imagerie
Fichier non déposé

Dates et versions

hal-01918720 , version 1 (11-11-2018)

Identifiants

  • HAL Id : hal-01918720 , version 1

Citer

T. Walter, D. Bruneton, P. A. Cassier, V. Hervieu, F. Pilleul, et al.. Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors. Clinical Colorectal Cancer, 2010, 9 (4), pp.248--254. ⟨hal-01918720⟩
14 Consultations
0 Téléchargements

Partager

More